Key Highlights
- EPS of $1.22 smashed the $0.59 consensus while net sales jumped 16% to $62.7 million.
- Net income rose 6% to $5.1 million and gross margin improved to 42.6% from 41.0% a year ago.
- U.S. sales surged 17% and European sales grew 24% in the quarter, driven by first-aid and cutting-tool lines.
- The company secured a new $65 million syndicated credit facility that runs until July 15, 2029.
Acme United Corp (NYSE American: ACU) posted earnings per share of $1.22 for the quarter ended June 30, 2026, well above the $0.59 consensus estimate. Net sales rose 16% to $62.7 million, and net income increased 6% to $5.1 million, lifting diluted EPS to $1.22. The earnings beat demonstrates the firm’s ability to generate growth despite a still-seasonal acquisition.
The stronger results give the company momentum to pursue further margin expansion.
EPS Beat and Sales Surge
The earnings surprise was anchored by a 16% lift in quarterly sales, up from $54.0 million a year earlier. Comparable three-month sales, excluding the My Medic acquisition, rose 8%, showing organic demand strength. Net income climbed to $5.1 million, a 6% increase over the prior year’s $4.8 million, while EPS moved from $1.16 to $1.22.
Gross margin widened to 42.6% from 41.0% previously, reflecting the contribution of higher-margin products. These figures illustrate that the company not only beat forecasts but also improved profitability on a per-share basis.
Segment Growth and Cost Structure
U.S. sales jumped 17% in the quarter, with first-aid revenue up 10% excluding My Medic’s impact and Westcott cutting tools rising 8%. European sales surged 24% in U.S.
dollars, driven by strong e-commerce and a recent German acquisition of a cutting-tool line. Canada showed modest growth, with a 1% rise in U.S.-dollar sales. Gross margin improvement to 42.6% stemmed from better product mix and tighter cost controls.
The company’s bank debt less cash stood at $27.3 million, and free cash flow for the twelve-month period reached $15.5 million, supporting a $65 million revolving credit facility that replaces an earlier $65 million line and runs through July 15, 2029. These operational gains, coupled with a healthier balance sheet, enable the firm to fund future acquisitions or increase shareholder returns.
Stock Moves and Peer Context
Acme United’s shares have seen positive movements, having risen significantly year-to-date and recently showing resilience in the market. The market capitalization sits at $179 million, with the stock floating within a 52-week range of $35.50 to $50.00. Sector peers were little changed, while one notable competitor experienced a decline, highlighting Acme United’s relative strength.
Insider transactions have occurred, but they did not alter market sentiment. The current price action underscores investor confidence amid solid earnings, but the proximity to the upper end of the 52-week range may test price resilience.
Upcoming Credit Facility Maturity
The newly arranged $65 million syndicated credit facility, anchored by HSBC Bank USA and City National Bank, expires on July 15, 2029. As that date approaches, investors will scrutinize any refinancing terms that could affect leverage ratios or dividend policy. The upcoming third-quarter results will provide the first major performance update after the facility’s inception, offering a forward-looking gauge of how the company manages its enlarged capital structure.
Monitoring the July 15, 2029 expiry will be essential for assessing future liquidity risk.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.
_11_19_2026_19_19_13_574021.jpg)





Please wait processing your request...